Loading…

Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt

Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes trea...

Full description

Saved in:
Bibliographic Details
Published in:Infection and drug resistance 2019-05, Vol.12, p.1113-1125
Main Authors: Said, Heba Shehta, Abdelmegeed, Eman Salama
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3
cites
container_end_page 1125
container_issue
container_start_page 1113
container_title Infection and drug resistance
container_volume 12
creator Said, Heba Shehta
Abdelmegeed, Eman Salama
description Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes treatment of enterococcal infections challenging. The aim of the study was to evaluate the antimicrobial resistance pattern, and assess the prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) among enterococcal isolates, collected from different clinical sources, in Mansoura University Hospitals, Egypt. Antibiotic sensitivity testing revealed elevated levels of resistance among enterococcal clinical isolates (N=103). All (N=32) and 74.6% of (N=71) were MDR, while two and four isolates were XDR. High level gentamicin resistance was detected in 79.6%, most of them carried the gene. High level streptomycin resistance was seen in 36.9%, of which 52.6% carried the gene. Resistance to macrolides and lincosamides were mediated by (92.2%) and (42.7%). , , and genes were detected among tetracyclines resistant isolates. Resistance to vancomycin was detected in 15.5%, where and gene clusters were detected in VRE isolates. Ten isolates (9.7%) were resistant to linezolid, eight of which harbored the gene. Vancomycin and linezolid resistant enterococci were more likely to exhibit strong/moderate biofilm formation than vancomycin and linezolid sensitive ones. Elevated levels of resistance to different classes of antimicrobial agents and emergence of MDR and XDR strains pose a major threat with limited therapeutic options for infections caused by this emerging pathogen.
doi_str_mv 10.2147/IDR.S189341
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ed9c634f38b4467190cbcb0a68d0fc6b</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A610675978</galeid><doaj_id>oai_doaj_org_article_ed9c634f38b4467190cbcb0a68d0fc6b</doaj_id><sourcerecordid>A610675978</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3</originalsourceid><addsrcrecordid>eNptkl1rFDEUhgdRbKm98l4GBCnIrsnka3IjlLrqQkHw4zpkkjOzKTPJmmSK_fdm3bXsoslFDuc85yUneavqJUbLBlPxbv3h6_IbbiWh-El1jrFoF1wK8vQoPqsuU7pDZRHJqWieV2cEY9wKTM6raTVBHMAbqENfT_OYnY3zUEdILmW9y2tva_iVwSd3D_U_1Sn4oQafIQYTjNFjbUbn3S5wKYw6Q6qdr1fDwza_qJ71ekxweTgvqh8fV99vPi9uv3xa31zfLgyjLC-ooBKklQKsELRnWILVAgtqETOEtVowazkDSS0XDddGMtGLjiNkAdrGkItqvde1Qd-pbXSTjg8qaKf-JEIclI7ZmREUWGk4oT1pO0q5wBKZznRI89ai3vCuaL3fa23nbgJryqhRjyeipxXvNmoI94ozjBqCisDVQSCGnzOkrCaXDIyj9hDmpJqGNIUUnBX09R4ddLma830oimaHq2uOERdMirZQy_9QZVuYnAkeelfyJw1vjho2oMe8KV8zZxd8OgXf7kETQ0oR-scxMVI7v6niN3XwW6FfHb_MI_vXXeQ39kbQoQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2232102765</pqid></control><display><type>article</type><title>Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Said, Heba Shehta ; Abdelmegeed, Eman Salama</creator><creatorcontrib>Said, Heba Shehta ; Abdelmegeed, Eman Salama</creatorcontrib><description>Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes treatment of enterococcal infections challenging. The aim of the study was to evaluate the antimicrobial resistance pattern, and assess the prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) among enterococcal isolates, collected from different clinical sources, in Mansoura University Hospitals, Egypt. Antibiotic sensitivity testing revealed elevated levels of resistance among enterococcal clinical isolates (N=103). All (N=32) and 74.6% of (N=71) were MDR, while two and four isolates were XDR. High level gentamicin resistance was detected in 79.6%, most of them carried the gene. High level streptomycin resistance was seen in 36.9%, of which 52.6% carried the gene. Resistance to macrolides and lincosamides were mediated by (92.2%) and (42.7%). , , and genes were detected among tetracyclines resistant isolates. Resistance to vancomycin was detected in 15.5%, where and gene clusters were detected in VRE isolates. Ten isolates (9.7%) were resistant to linezolid, eight of which harbored the gene. Vancomycin and linezolid resistant enterococci were more likely to exhibit strong/moderate biofilm formation than vancomycin and linezolid sensitive ones. Elevated levels of resistance to different classes of antimicrobial agents and emergence of MDR and XDR strains pose a major threat with limited therapeutic options for infections caused by this emerging pathogen.</description><identifier>ISSN: 1178-6973</identifier><identifier>EISSN: 1178-6973</identifier><identifier>DOI: 10.2147/IDR.S189341</identifier><identifier>PMID: 31118713</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Aminoglycosides ; Antibacterial agents ; antibiotic resistance ; Antibiotics ; biofilm formation ; Drug resistance ; Drug therapy ; Egypt ; Enterococcal infections ; Enterococci ; Gastrointestinal system ; Genes ; Health aspects ; Hospital patients ; Hospitals ; Imipenem ; Infection ; Linezolid ; Linezolid resistant enterococci ; MDR enterococci ; Meropenem ; Microbial drug resistance ; Morbidity ; Original Research ; RAPD typing ; Tetracyclines ; Vancomycin ; VRE ; XDR enterococci</subject><ispartof>Infection and drug resistance, 2019-05, Vol.12, p.1113-1125</ispartof><rights>COPYRIGHT 2019 Dove Medical Press Limited</rights><rights>2019 Said and Abdelmegeed. This work is published and licensed by Dove Medical Press Limited 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510230/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510230/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,36990,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31118713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Said, Heba Shehta</creatorcontrib><creatorcontrib>Abdelmegeed, Eman Salama</creatorcontrib><title>Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt</title><title>Infection and drug resistance</title><addtitle>Infect Drug Resist</addtitle><description>Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes treatment of enterococcal infections challenging. The aim of the study was to evaluate the antimicrobial resistance pattern, and assess the prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) among enterococcal isolates, collected from different clinical sources, in Mansoura University Hospitals, Egypt. Antibiotic sensitivity testing revealed elevated levels of resistance among enterococcal clinical isolates (N=103). All (N=32) and 74.6% of (N=71) were MDR, while two and four isolates were XDR. High level gentamicin resistance was detected in 79.6%, most of them carried the gene. High level streptomycin resistance was seen in 36.9%, of which 52.6% carried the gene. Resistance to macrolides and lincosamides were mediated by (92.2%) and (42.7%). , , and genes were detected among tetracyclines resistant isolates. Resistance to vancomycin was detected in 15.5%, where and gene clusters were detected in VRE isolates. Ten isolates (9.7%) were resistant to linezolid, eight of which harbored the gene. Vancomycin and linezolid resistant enterococci were more likely to exhibit strong/moderate biofilm formation than vancomycin and linezolid sensitive ones. Elevated levels of resistance to different classes of antimicrobial agents and emergence of MDR and XDR strains pose a major threat with limited therapeutic options for infections caused by this emerging pathogen.</description><subject>Aminoglycosides</subject><subject>Antibacterial agents</subject><subject>antibiotic resistance</subject><subject>Antibiotics</subject><subject>biofilm formation</subject><subject>Drug resistance</subject><subject>Drug therapy</subject><subject>Egypt</subject><subject>Enterococcal infections</subject><subject>Enterococci</subject><subject>Gastrointestinal system</subject><subject>Genes</subject><subject>Health aspects</subject><subject>Hospital patients</subject><subject>Hospitals</subject><subject>Imipenem</subject><subject>Infection</subject><subject>Linezolid</subject><subject>Linezolid resistant enterococci</subject><subject>MDR enterococci</subject><subject>Meropenem</subject><subject>Microbial drug resistance</subject><subject>Morbidity</subject><subject>Original Research</subject><subject>RAPD typing</subject><subject>Tetracyclines</subject><subject>Vancomycin</subject><subject>VRE</subject><subject>XDR enterococci</subject><issn>1178-6973</issn><issn>1178-6973</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNptkl1rFDEUhgdRbKm98l4GBCnIrsnka3IjlLrqQkHw4zpkkjOzKTPJmmSK_fdm3bXsoslFDuc85yUneavqJUbLBlPxbv3h6_IbbiWh-El1jrFoF1wK8vQoPqsuU7pDZRHJqWieV2cEY9wKTM6raTVBHMAbqENfT_OYnY3zUEdILmW9y2tva_iVwSd3D_U_1Sn4oQafIQYTjNFjbUbn3S5wKYw6Q6qdr1fDwza_qJ71ekxweTgvqh8fV99vPi9uv3xa31zfLgyjLC-ooBKklQKsELRnWILVAgtqETOEtVowazkDSS0XDddGMtGLjiNkAdrGkItqvde1Qd-pbXSTjg8qaKf-JEIclI7ZmREUWGk4oT1pO0q5wBKZznRI89ai3vCuaL3fa23nbgJryqhRjyeipxXvNmoI94ozjBqCisDVQSCGnzOkrCaXDIyj9hDmpJqGNIUUnBX09R4ddLma830oimaHq2uOERdMirZQy_9QZVuYnAkeelfyJw1vjho2oMe8KV8zZxd8OgXf7kETQ0oR-scxMVI7v6niN3XwW6FfHb_MI_vXXeQ39kbQoQ</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Said, Heba Shehta</creator><creator>Abdelmegeed, Eman Salama</creator><general>Dove Medical Press Limited</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20190501</creationdate><title>Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt</title><author>Said, Heba Shehta ; Abdelmegeed, Eman Salama</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aminoglycosides</topic><topic>Antibacterial agents</topic><topic>antibiotic resistance</topic><topic>Antibiotics</topic><topic>biofilm formation</topic><topic>Drug resistance</topic><topic>Drug therapy</topic><topic>Egypt</topic><topic>Enterococcal infections</topic><topic>Enterococci</topic><topic>Gastrointestinal system</topic><topic>Genes</topic><topic>Health aspects</topic><topic>Hospital patients</topic><topic>Hospitals</topic><topic>Imipenem</topic><topic>Infection</topic><topic>Linezolid</topic><topic>Linezolid resistant enterococci</topic><topic>MDR enterococci</topic><topic>Meropenem</topic><topic>Microbial drug resistance</topic><topic>Morbidity</topic><topic>Original Research</topic><topic>RAPD typing</topic><topic>Tetracyclines</topic><topic>Vancomycin</topic><topic>VRE</topic><topic>XDR enterococci</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Said, Heba Shehta</creatorcontrib><creatorcontrib>Abdelmegeed, Eman Salama</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Infection and drug resistance</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Said, Heba Shehta</au><au>Abdelmegeed, Eman Salama</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt</atitle><jtitle>Infection and drug resistance</jtitle><addtitle>Infect Drug Resist</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>12</volume><spage>1113</spage><epage>1125</epage><pages>1113-1125</pages><issn>1178-6973</issn><eissn>1178-6973</eissn><abstract>Enterococci commonly inhabit the gastrointestinal tract of both human and animals; however, they have emerged as a leading cause of several infections with substantial morbidity and mortality. Their ability to acquire resistance combined with intrinsic resistance to various antimicrobials makes treatment of enterococcal infections challenging. The aim of the study was to evaluate the antimicrobial resistance pattern, and assess the prevalence of multidrug resistance (MDR) and extensive drug resistance (XDR) among enterococcal isolates, collected from different clinical sources, in Mansoura University Hospitals, Egypt. Antibiotic sensitivity testing revealed elevated levels of resistance among enterococcal clinical isolates (N=103). All (N=32) and 74.6% of (N=71) were MDR, while two and four isolates were XDR. High level gentamicin resistance was detected in 79.6%, most of them carried the gene. High level streptomycin resistance was seen in 36.9%, of which 52.6% carried the gene. Resistance to macrolides and lincosamides were mediated by (92.2%) and (42.7%). , , and genes were detected among tetracyclines resistant isolates. Resistance to vancomycin was detected in 15.5%, where and gene clusters were detected in VRE isolates. Ten isolates (9.7%) were resistant to linezolid, eight of which harbored the gene. Vancomycin and linezolid resistant enterococci were more likely to exhibit strong/moderate biofilm formation than vancomycin and linezolid sensitive ones. Elevated levels of resistance to different classes of antimicrobial agents and emergence of MDR and XDR strains pose a major threat with limited therapeutic options for infections caused by this emerging pathogen.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>31118713</pmid><doi>10.2147/IDR.S189341</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-6973
ispartof Infection and drug resistance, 2019-05, Vol.12, p.1113-1125
issn 1178-6973
1178-6973
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ed9c634f38b4467190cbcb0a68d0fc6b
source Taylor & Francis Open Access; Publicly Available Content Database; PubMed Central
subjects Aminoglycosides
Antibacterial agents
antibiotic resistance
Antibiotics
biofilm formation
Drug resistance
Drug therapy
Egypt
Enterococcal infections
Enterococci
Gastrointestinal system
Genes
Health aspects
Hospital patients
Hospitals
Imipenem
Infection
Linezolid
Linezolid resistant enterococci
MDR enterococci
Meropenem
Microbial drug resistance
Morbidity
Original Research
RAPD typing
Tetracyclines
Vancomycin
VRE
XDR enterococci
title Emergence of multidrug resistance and extensive drug resistance among enterococcal clinical isolates in Egypt
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T03%3A39%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emergence%20of%20multidrug%20resistance%20and%20extensive%20drug%20resistance%20among%20enterococcal%20clinical%20isolates%20in%20Egypt&rft.jtitle=Infection%20and%20drug%20resistance&rft.au=Said,%20Heba%20Shehta&rft.date=2019-05-01&rft.volume=12&rft.spage=1113&rft.epage=1125&rft.pages=1113-1125&rft.issn=1178-6973&rft.eissn=1178-6973&rft_id=info:doi/10.2147/IDR.S189341&rft_dat=%3Cgale_doaj_%3EA610675978%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c545t-4749e9d97ed774f519eda7174d05c358a75dd65e94d6726ac957f7b600dee82c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2232102765&rft_id=info:pmid/31118713&rft_galeid=A610675978&rfr_iscdi=true